Book Review: Jess Walter's 'So Far Gone' sets a redemption story in fractured, modern America
When the history of the United States in 2025 is written, perhaps one of the best things that will be said is: 'Well, it made for some great art.'
Consider 'So Far Gone,' the new novel by Jess Walter. Set in present day America, it opens with two kids wearing backpacks knocking on a cabin door. 'What are you fine young capitalists selling?' asks Rhys Kinnick, before realizing the kids are his grandchildren. They carry with them a note from Kinnick's daughter, describing dad as a 'recluse who cut off contact with our family and now lives in squalor in a cabin north of Spokane.'
It's a great hook that draws you in and doesn't really let up for the next 256 pages. We learn why Kinnick pulled a Thoreau and went to the woods seven years ago , as well as the whereabouts of Kinnick's daughter, Bethany, and why her messy marriage to a guy named Shane led to Kinnick's grandchildren being dropped off at his cabin.
In a neat narrative gimmick, the chapters are entitled 'What Happened to ___' and fill in the main strokes of each character's backstory, as well as what happens to them in the present timeline. Told with an omniscient third-person sense of humor, the book's themes are nonetheless serious. On the demise of journalism in the chapter 'What Happened to Lucy,' one of Kinnick's old flames and colleagues at the Spokesman-Review: She 'hated that reporters were expected to constantly post on social media… before knowing what their stories even meant.' Or Kinnick's thoughts as he holds a .22 Glock given to him just in case by a retired police officer who is helping him get his grandkids back from the local militia: 'The shiver that went through his arm! The power!… The weight of this gun was the exact weight of his anger and his fear and his sense of displacement… That's where its incredible balance lay.'
As Kinnick links up with various characters and drives across the Northwest in search of his daughter and grandchildren, the plot unfolds quickly. Most readers won't need more than a day or two to reach the final page, which satisfies the Thoreau quote Walter uses in the story's preface: 'Not till we are lost… 'till we have lost the world, do we begin to find ourselves.'
book reviews: /hub/book-reviews
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Kendrick Lamar's ‘GNX' Wins Album of The Year at The 2025 BET Awards
Kendrick Lamar took home the award for Album of the Year at the 2025 BET Awards, beating out Beyoncé, The Weeknd, Drake, and more, and adding to the impressive string of accolades for the L.A. rapper following his now-infamous feud with Drake. His award was presented to him by actor Keke Palmer. During his acceptance speech, he acknowledged that he hasn't often attended the BET Awards in recent years, but said it's always been important to him. 'I ain't been here in a long time,' he said, 'BET always makes sure that they represent the culture right, and always put me in the midst of the cycle of what we represent, and that's real, true down to Earth music that people can feel. So I always give my heart to BET.' He looked towards the back of the crowd and showed out 'All my L.A. natives' before thanking God and his company, PG Lang. More from Rolling Stone Teyana Taylor Makes the BET Awards Her 'Escape Room' in Fiery Performance Lil Wayne Wows the BET Awards With 'A Milli' Performance Doechii Slams Trump's L.A. Protest Crackdown While Accepting BET Award He also shouted out SZA, who was also in attendance and added, 'We on tour right now, please come to the show.' They are in fact in the middle of their Grand National tour, which finishes its North American dates this month and hits Europe in July. Lamar, who is the night's most nominated act, was handed a slew of additional trophies by host Kevin Hart, though the particulars of the awards were not named. Best of Rolling Stone Sly and the Family Stone: 20 Essential Songs The 50 Greatest Eminem Songs All 274 of Taylor Swift's Songs, Ranked
Black America Web
29 minutes ago
- Black America Web
Sly Stone's Music Formed The Backdrop To Several Hip-Hop Classics
Sly Stone, a legendary musician who helped propel funk to its elevated heights in the realm of Black music, has died. Hip-Hop artists of various eras have sampled Sly Stone's work over the years, and we've got a playlist highlighting some of those audio classics. As Hip-Hop Wired reported earlier, Sly Stone, born Sylvester Stewart in Denton, Texas, passed away Monday (June 9) at the age of 82. After establishing his roots in the Bay Area as a musical prodigy, Stone ventured into becoming a front-facing artist with his Sly and The Stones in the 1960s with the late Cynthia Robinson, the trumpeter who was a founding member of Sly and the Family Stone, the band that catapulted Stone into the annals of music history. Alongside fun pioneers such asJames Brown and Parliament-Funkadelic, Stone and his band enjoyed a successful run of album releases extending into the late 1970s. Stone's life was captured in the 2023 biography, Thank You (Falettinme Be Mice Elf Agin), written with Ben Greenman, featuring a foreword from Ahmir 'Questlove' Thompson. Thompson also produced the stirring 2025 documentary centered on Stone's life and legacy, Sly Lives! (aka the Burden of Black Genius) . Hip-Hop artists such as LL Cool J, Queen Latifah, The Jungle Brothers, Public Enemy, and scores more dug into the crates to grab bits of Stone's music to form the backdrop of their works. Below, we've got a handful of those songs featured in the playlist below. Long live Sly Stone. May he rest powerfully in peace. — Photo: Michael Putland / Getty Sly Stone's Music Formed The Backdrop To Several Hip-Hop Classics was originally published on Samples 'Trip To Your Heart.' Samples 'Dance to the Music.' Samples 'You Can Make It If You Try.' Samples 'Sing A Simple Song.' Samples 'Everyday People.' Black America Web Featured Video CLOSE
Yahoo
29 minutes ago
- Yahoo
AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer's Disease
Seongnam-si, South Korea and Abu Dhabi, UAE, June 09, 2025 (GLOBE NEWSWIRE) -- AriBio Co., Ltd. ("AriBio"), a South Korean biopharmaceutical company specializing in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of Arcera, a global life sciences company based in Abu Dhabi (collectively 'Arcera'), today announced the signing of exclusive licensing and commercialization, and supply agreements for AR1001, an investigational oral therapy for Alzheimer's disease. Under the terms of the agreements, Arcera will have exclusive rights to commercialize AR1001 in its key markets, including Latin America, the Middle East, Southern Africa, Ukraine and select Eurasian countries. AriBio will be responsible for manufacturing and supplying the product. The total deal value is estimated at USD 600 million across the development, launch and commercialization period, contingent upon the achievement of certain milestones. AR1001 is a novel, disease-modifying, once-daily oral phosphodiesterase-5 (PDE5) inhibitor currently being studied in a global Phase 3 clinical trial (POLARIS-AD) for the treatment of early-stage Alzheimer's disease. The enrollment target for the Phase 3 trial has been reached, and the topline results are expected in the first half of 2026. Facilitated by the Korea Development Bank (KDB) and aligned with the Korean government's policy to foster the biohealth industry, this collaboration represents a significant step forward to enhance the global competitiveness of Korea's pharmaceutical and biotech industry. "This partnership with Arcera marks a significant milestone in our mission to bring innovative treatments to patients worldwide," said Jai Jun Choung, CEO of AriBio. "Arcera's strong commercial capabilities and deep understanding of the high-growth markets make them an ideal partner to advance AR1001 in these important regions." "We are excited to enter into this collaboration with AriBio, which will provide access to AR1001, a novel treatment, for patients across these countries," said Isabel Afonso, CEO of Arcera. "This agreement aligns with our strategy to expand our neuroscience portfolio and reinforces our commitment to providing access to novel therapies in regions with significant unmet medical needs." The agreement underscores both companies' dedication to addressing unmet medical needs in neurodegenerative diseases and enhancing patient access to innovative therapies globally. This deal follows the Memorandum of Understanding signed between AriBio and Arcera in March 2025, where both parties agreed to strengthen their partnership by actively exploring strategic investments, and advancing joint research and development based on shared interests. ENDS About AriBio Co., Ltd. Founded in 2010, AriBio is a clinical-stage biopharmaceutical company headquartered in South Korea, with offices located in the United States to manage global clinical operations and regulatory affairs. The company focuses on the development of novel therapies for neurodegenerative diseases, including Alzheimer's disease. AriBio continues to expand its partnerships to accelerate the development and delivery of life-changing treatments to patients worldwide. About Arcera Arcera is a global life sciences company, headquartered in Abu Dhabi. Arcera develops, manufactures, and commercializes a broad range of high-quality proven and innovative medicines in key international markets. Its portfolio exceeds 2,000 medicines covering wide therapeutic areas which reach patients in ninety countries in four continents, backed by manufacturing and packing sites across the world. Arcera was established by the sovereign wealth fund, ADQ to realize Abu Dhabi's ambition as a global leader in innovative and sustainable healthcare. To learn more about Arcera, visit Attachment AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer's Disease CONTACT: Tanya Xi, MD, PhD, MBA, Senior Director, Business Development & Medical Affairs, AriBio (US) AriBio Co., Ltd. tanyaxi@ Rafael Ferrer, SVP Corporate Development. Arcera rferrer@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
